Literature DB >> 16293584

Murine bone marrow stromal cells sustain in vivo the survival of hematopoietic stem cells and the granulopoietic differentiation of more mature progenitors.

Frédérique Hubin1, Chantal Humblet, Zakia Belaid, Charles Lambert, Jacques Boniver, Albert Thiry, Marie-Paule Defresne.   

Abstract

The study of the human hematopoietic system would be facilitated by availability of a relevant animal model. Because the medullar microenvironment is made of different types of cells, interactions between hematopoietic cells and stromal cells are difficult to analyze in detail. As an approach for establishing an in vivo model to dissect these interactions, we grafted murine bone marrow fibroblastic cells (MS-5 cell line) with hematopoietic cells into the kidney capsule of syngenic mice. To identify the origin of cells present in the graft, we used green fluorescent protein-stable transfected MS-5 cells for the transplantation. To analyze the evolution of stromal cells and identify hematopoietic cells able to develop in these conditions, we performed morphology, histochemistry, and immunohistology on tissue sections at different times after transplantation. When injected alone, MS-5 cells differentiate into adipocytes. When injected with a bone marrow suspension or with isolated CD45+ cells (leukocytes), the stromal cells keep their fibroblastic morphology and their alkaline phosphatase expression and sustain granulopoiesis. When injected with hematopoietic stem cells called c-kit+ Sca-1+ Lin- suspension, clusters of hematopoietic cells are also observed: They do not present any granulopoietic activity and do not belong to B or T population nor to erythroid lineage. They are quiescent, induce bone marrow recovery and survival of lethally irradiated recipients, are able to form macroscopic colonies in the spleen, and are able to form very few colonies in vitro, suggesting that they are hematopoietic stem cells. In conclusion, our results show that reticular fibroblastic stromal cells MS-5 sustain the survival of stem cells and are not able to induce their differentiation. However, they can control differentiation, proliferation, and/or survival of hematopoietic cells engaged in myeloid lineage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16293584     DOI: 10.1634/stemcells.2005-0041

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  6 in total

1.  Treatment of Full-Thickness Skin Wounds with Blood-Derived CD34+ Precursor Cells Enhances Healing with Hair Follicle Regeneration.

Authors:  Shaowei Li; Min Hu; H Peter Lorenz
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-03-19       Impact factor: 4.730

2.  Development of a zebrafish spleen cell line, ZSSJ, and its growth arrest by gamma irradiation and capacity to act as feeder cells.

Authors:  J G Xing; W El-Sweisi; L E J Lee; P Collodi; C Seymour; C Mothersill; N C Bols
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-12-31       Impact factor: 2.416

Review 3.  Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis.

Authors:  Anthony J Cura; Anthony Carruthers
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

4.  Characterization of spontaneous bone marrow recovery after sublethal total body irradiation: importance of the osteoblastic/adipocytic balance.

Authors:  Géraldine Poncin; Aurore Beaulieu; Chantal Humblet; Albert Thiry; Kimimitsu Oda; Jacques Boniver; Marie-Paule Defresne
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

5.  In vitro inhibitory effects of imatinib mesylate on stromal cells and hematopoietic progenitors from bone marrow.

Authors:  P B Soares; T S Jeremias; M Alvarez-Silva; M A Licinio; M C Santos-Silva; C L Vituri
Journal:  Braz J Med Biol Res       Date:  2012-09-25       Impact factor: 2.590

6.  Cobblestone-area forming cells derived from patients with mantle cell lymphoma are enriched for CD133+ tumor-initiating cells.

Authors:  Daniel J Medina; Jeneba Abass-Shereef; Kelly Walton; Lauri Goodell; Hana Aviv; Roger K Strair; Tulin Budak-Alpdogan
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.